MOLN vs REGN: Which Stock is Better?
Side-by-side comparison of Molecular Partners AG ADR and Regeneron Pharmaceuticals Inc in 2026
MOLN
Molecular Partners AG ADR
—
REGN
Regeneron Pharmaceuticals Inc
$672.15
Key Metrics Comparison
| Metric | MOLN | REGN | Winner |
|---|---|---|---|
| Market Cap | $146.29M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze MOLN
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MOLN or REGN a better investment?
Comparing MOLN and REGN: Molecular Partners AG ADR has a market cap of $146.29M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MOLN and REGN?
MOLN (Molecular Partners AG ADR) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MOLN or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MOLN or REGN?
Both MOLN and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: MOLN or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: MOLN or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $146.29M for MOLN.
Should I buy MOLN or REGN in 2026?
Both MOLN and REGN have investment merit. MOLN trades at $N/A while REGN trades at $672.15. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MOLN and REGN stock?
Key differences: Market Cap ($146.29M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy MOLN or REGN in 2026?
The choice between MOLN and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between MOLN and REGN?
MOLN (Molecular Partners AG ADR) has a market cap of $146.29M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.